Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases

被引:273
作者
Peña, C
Pujol, M
Ardanuy, C
Ricart, A
Pallares, R
Liñares, J
Ariza, J
Gudiol, F
机构
[1] Univ Barcelona, Bellvitge Hosp, Infect Dis Serv, Barcelona 08907, Spain
[2] Univ Barcelona, Bellvitge Hosp, Microbiol Serv, Barcelona 08907, Spain
[3] Univ Barcelona, Bellvitge Hosp, Intens Care Unit Serv, Barcelona 08907, Spain
关键词
D O I
10.1128/AAC.42.1.53
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
An outbreak due to extended-spectrum beta-lactamase-producing Klebsiella pneumoniae (ESBL-KP) was detected from May 1993 to June 1995. A total of 145 patients, particularly patients in intensive care units (ICUs) (107 patients [72%]), were colonized or infected, Infection developed in 92 (63%) patients, and primary bacteremia caused by ESBL-KP was the most frequent infection (40 of 92 patients [43%]). A single clone of ESBL-KP was identified by pulsed-field gel electrophoresis analysis throughout the whole period, and no molecular epidemiological relationship could be found between the epidemic strain and non-ESBL-KP isolates. To determine risk factors for ESBL-KP infection weekly rectal swabs were obtained in three serial incidence surveys (470 patients); the probabilities of carriage of ESBL-KP in the digestive tract were 33% (October and November 1993), 40% (May and June 1994), and 0% (October and November 1995) at 10 days of ICU admission, A logistic regression model identified prior carriage of ESBL-KP in the digestive tract (odds ratio, 3.4; 95% confidence interval 1.1 to 10.4) as an independent variable associated with ESBL-KP infection, A statistically significant correlation was observed between the restricted use of oxyimino-beta-lactams (189 defined daily doses [DDD]/1,000 patient-days to 24 DDD/1,000 patient-days) and the trends of ESBL-KP infection (r = 0.7; P = 0.03).
引用
收藏
页码:53 / 58
页数:6
相关论文
共 37 条
[1]   MOLECULAR EPIDEMIOLOGY OF KLEBSIELLA-PNEUMONIAE STRAINS THAT PRODUCE SHV-4 BETA-LACTAMASE AND WHICH WERE ISOLATED IN 14 FRENCH HOSPITALS [J].
ARLET, G ;
ROUVEAU, M ;
CASIN, I ;
BOUVET, PJM ;
LAGRANGE, PH ;
PHILIPPON, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (10) :2553-2558
[2]   OUTBREAK OF NOSOCOMIAL INFECTIONS DUE TO KLEBSIELLA-PNEUMONIAE PRODUCING SHV-4 BETA-LACTAMASE [J].
ARLET, G ;
SANSONLEPORS, MJ ;
ROUVEAU, M ;
FOURNIER, G ;
MARIE, O ;
SCHLEMMER, B ;
PHILIPPON, A .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (11) :797-803
[3]   EFFECT OF BROAD-SPECTRUM PARENTERAL ANTIBIOTICS ON COLONIZATION RESISTANCE OF INTESTINAL MICROFLORA OF HUMANS [J].
BARZA, M ;
GIULIANO, M ;
JACOBUS, NV ;
GORBACH, SL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (05) :723-727
[4]   SPREAD OF KLEBSIELLA-PNEUMONIAE PRODUCING SHV-5 BETA-LACTAMASE AMONG HOSPITALIZED-PATIENTS [J].
BAUERNFEIND, A ;
ROSENTHAL, E ;
EBERLEIN, E ;
HOLLEY, M ;
SCHWEIGHART, S .
INFECTION, 1993, 21 (01) :18-22
[5]  
Boyce JM, 1996, INFECT CONT HOSP EP, V17, P256
[6]  
BRUNBUISSON C, 1987, LANCET, V2, P302
[7]   INTESTINAL DECONTAMINATION FOR CONTROL OF NOSOCOMIAL MULTIRESISTANT GRAM-NEGATIVE BACILLI - STUDY OF AN OUTBREAK IN AN INTENSIVE-CARE UNIT [J].
BRUNBUISSON, C ;
LEGRAND, P ;
RAUSS, A ;
RICHARD, C ;
MONTRAVERS, F ;
BESBES, M ;
MEAKINS, JL ;
SOUSSY, CJ ;
LEMAIRE, F .
ANNALS OF INTERNAL MEDICINE, 1989, 110 (11) :873-881
[8]   R-PLASMID-ENCODED ADHESIVE FACTOR IN KLEBSIELLA-PNEUMONIAE STRAINS RESPONSIBLE FOR HUMAN NOSOCOMIAL INFECTIONS [J].
DARFEUILLE-MICHAUD, A ;
JALLAT, C ;
AUBEL, D ;
SIROT, D ;
RICH, C ;
SIROT, J ;
JOLY, B .
INFECTION AND IMMUNITY, 1992, 60 (01) :44-55
[9]   PROSPECTIVE SURVEY OF COLONIZATION AND INFECTION CAUSED BY EXPANDED-SPECTRUM-BETA-LACTAMASE-PRODUCING MEMBERS OF THE FAMILY ENTEROBACTERIACEAE IN AN INTENSIVE-CARE UNIT [J].
DECHAMPS, C ;
SAUVANT, MP ;
CHANAL, C ;
SIROT, D ;
GAZUY, N ;
MALHURET, R ;
BAGUET, JC ;
SIROT, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (12) :2887-2890
[10]   A new fimbrial antigen harbored by CAZ-5/SHV-4-producing Klebsiella pneumoniae strains involved in nosocomial infections [J].
DiMartino, P ;
Livrelli, V ;
Sirot, D ;
Joly, B ;
Darfeuille-Michaud, A .
INFECTION AND IMMUNITY, 1996, 64 (06) :2266-2273